Pharma Stocks Slip as Trump Targets Drug Prices, Pushes Local Production

Domestic pharma stocks fell on May 9, with Nifty Pharma down 1.7%, after Donald Trump pledged to slash U.S. drug prices and boost local manufacturing. The move threatens Indian generic drug exports, raising concerns over revenue impact and compliance costs amid rising U.S. protectionism in pharma.